Plant Based Diet

Advancing Science

Plant-Based Diets: Beneficial for Prostate Cancer?

Systematic review ties plant-based regimen to reduced prostate cancer risk, improved outcomes, and overall health.

Read More

NYU Langone Health: A Leader in Urology

urology 2022 badge

Ranked #10

in Urology

Top 10

in NIH funding (Source: Blue Ridge)

Pioneers in MRI

to evaluate prostate cancer

Complex Case Spotlight

Challenges in Managing Small Renal Masses

CT Scan with Mass

Malignant Appearing Small Mass to Oncocytoma

For the first case, a healthy, 39-year-old man presented with abdominal pain, and a CT scan revealed a 2.2 centimeter enhancing solid mass (red circle). The man received a robotic partial nephrectomy. Upon pathology, the excised oncocytoma showed diffuse reactivity for the oncogenic marker CD117 and scattered positivity for CK7.

1 of 3
CT Scan with Cyst

Benign Multi-Locular Cyst Appears as a Suspicious Malignant Cyst

In a second case, providers identified a mass in a healthy 54-year-old man: an incidental 2.5 centimeter complex cyst on chest CT (red circle) that was later confirmed via MRI as a 2.6 centimeter cystic left upper pole renal lesion. The septated mass had a thick rim and was rated Bosniak category III.

2 of 3
CT Scan Showing Carcinoma

Comorbidity Considerations Essential

The third case involved a 59-year-old man with a history of cardiovascular conditions, including coronary artery disease, severe aortic regurgitation, a cerebrovascular accident, and a thoracic aortic aneurysm repair. He had a biopsy-proven, enlarging solid 2.2 centimeter papillary renal cell carcinoma (red circle). READ THE FULL ARTICLE

3 of 3

NYULH is proud to be ranked the #3 hospital in the U.S.

Refer a Patient

Your Partner in Every Patient’s Care

To refer a patient, browse our specialists.

Subscribe for Updates in Urology

Sign up for Physician Focus emails for practice-changing news and perspectives from our experts at NYU Langone Health.

Select Your Interests

CME, Symposia & Events

Surgical, Pharmacological, and Technological Advances in Urology

December 8 – 10, 2022

NYU Langone Health, 550 First Avenue, Alumni Hall
7:45 AM ET

The diagnosis and management of many urologic diseases have been greatly influenced by recent pharmacological, surgical, and technological advances. This update, led by an internationally acclaimed faculty, will provide presentations on male sexual dysfunction, endourology, voiding dysfunction, prostate cancer, reconstructive urology, and chronic pelvic pain. In this live format, case presentations and Q&As will enhance the didactic lectures.

Register Now